DCGI approves clinical trials for Duchenne muscular dystrophy

DCGI

The country’s first-ever human clinical trial for a drug to overcome a genetic disorder named Duchenne muscular dystrophy has been approved by the Drugs Controller General of India. This disorder affects around five lakh male children in India. Nine hospitals will conduct trials across the nation in 2021. The drug is based on personalized genetic intervention and will be the first of it’s kind to treat this disease in the country. As per the order issued by Dr. V G Somani (Drugs Controller General of India), Dystrophy Annihilation Research Trust…

Read More